St. Joseph's Health Care London

Dr. Joaquin Sanchez-Sotelo of Mayo Clinic and Dr. George Athwall of St. Joseph’s Health Care (London, Canada) performed the surgeries. Kalamazoo, Michigan–based Stryker designed its Blueprint MR guidance system to combine software with the Microsoft HoloLens 2 headset. It allows the surgeon to track the position and orientation of surgical instrumentation in the physical environment. Blueprint MR guidance uses 3D images and widgets to guide surgeons and their instruments. Displayed on the patient and in the surgeon’s line of sight, the images and widgets avoid disrupting the surgical workflow. The FDA cleared this system about a year ago. Dr. Sanchez-Sotelo said individualized care platforms can cater to each patient’s unique anatomy. “Mixed reality technology offers important benefits to patients,” said Dr. Sanchez-Sotelo, one of the Blueprint design surgeons. “This technology allows the surgeon to plan and execute the surgery based on precise images of the patient’s shoulder, thereby minimizing the risk of improper placement of the implant.” Stryker’s previous Blueprint system was used by more than 50 surgeons in more than 3,500 shoulder replacement procedures globally. The company expects the completion of the first case using the new Blueprint system in Europe next month, too. “The addition of mixed reality guidance to our Blueprint platform has the potential to benefit the entire shoulder arthroplasty market – surgeons and patients alike,” said Tim Lanier, president of Stryker’s Trauma & Extremities division. “Now that Mixed Reality Guidance has officially entered the operating room, our surgeons will have access to the most innovative technology available, enabling more precise surgical results and allowing for improved results for patients.”

KALAMAZOO, Mich.--( BUSINESS WIRE )--Stryker (NYSE:SYK), one of the world’s leading medical technology companies, today announced that the first shoulder arthroplasty surgeries using Blueprint ® Mixed Reality (MR) Guidance have been successfully completed by Dr. Joaquin Sanchez-Sotelo, MD, PhD, Consultant and Professor of Orthopedic Surgery at Mayo Clinic in Rochester, Minn., and Dr. George Athwal at St. Joseph’s Health Care London, Canada. “Mixed reality technology offers important benefits to patients,” said Dr. Sanchez-Sotelo, one of the Blueprint design surgeons. “This technology allows the surgeon to plan and execute the surgery based on precise images of the patient’s shoulder, thereby minimizing the risk of improper placement of the implant. This is individualized care tailored to each patient’s anatomy.” Designed by a team of world-class surgeons, the Blueprint MR Guidance System combines Stryker's innovative software with the Microsoft HoloLens™ 2* headset, allowing the surgeon to track the position and orientation of surgical instrumentation in the physical environment. Blueprint MR Guidance allows surgeons and their instruments to be ‘guided’ by 3D images and guidance widgets, which can be displayed on the patient and in the surgeon’s line of sight without disrupting normal workflow. The MR Guidance system received FDA clearance in January 2023. “The addition of Mixed Reality Guidance to our Blueprint platform has the potential to benefit the entire shoulder arthroplasty market – surgeons and patients alike,” said Tim Lanier, president of Stryker’s Trauma & Extremities division. “Now that Mixed Reality Guidance has officially entered the operating room, our surgeons will have access to the most innovative technology available, enabling more precise surgical results and allowing for improved results for patients.” Blueprint Mixed Reality OR Visualization , the previous iteration of Stryker’s Blueprint Mixed Reality, has been used by over 50 surgeons and in more than 3,500 shoulder replacement procedures globally. To learn more about Blueprint and Mixed Reality, visit shoulderblueprint.com . Stryker anticipates the completion of the first case utilizing the Blueprint ® Mixed Reality (MR) Guidance System in Europe in February, marking a significant milestone in advancing surgical technology globally. About Stryker Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com . ____________ Mayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research. Dr. Joaquin Sanchez-Sotelo is a paid consultant of Stryker Trauma and Extremities. The opinions expressed by Dr. Joaquin Sanchez-Sotelo are those of Dr. Joaquin Sanchez-Sotelo and not necessarily those of Stryker. Individual experiences may vary. A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any product before using it in surgery. The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area. Stryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: Stryker. All other trademarks are trademarks of their respective owners or holders. Content ID: AP-017097A Copyright © 2024 Stryker * Used with permission from Microsoft

WEDNESDAY, July 26, 2023 -- The combination of aerobic and resistance exercises with computerized cognitive training may improve cognition in older adults with mild cognitive impairment (MCI), according to a study published online July 20 in JAMA Network Open . Manuel Montero-Odasso, M.D., Ph.D., from the Gait and Brain Lab at the Parkwood Institute in London, Ontario, Canada, and colleagues assessed whether aerobic-resistance exercises, computerized cognitive training, and vitamin D supplementation can enhance cognition among 175 older adults (aged 65 to 84 years) with MCI. The researchers found that at six months, all active intervention arms with aerobic-resistance exercise, regardless of the addition of cognitive training or vitamin D, significantly improved the Alzheimer Disease Assessment Scale Cognitive 13 (ADAS-Cog-13) score versus control (mean difference, −1.79 points). Exercise and cognitive training significantly improved the ADAS-Cog-13 score compared with exercise alone (mean difference, −1.45 points). There was no significant improvement seen with vitamin D supplementation. "In this clinical trial, older adults with MCI receiving aerobic-resistance exercises with sequential computerized cognitive training significantly improved cognition, although some results were inconsistent. Vitamin D supplementation had no effect," the authors write. "Our findings suggest that this multidomain intervention may improve cognition and potentially delay dementia onset in MCI." One author disclosed ties to the pharmaceutical industry. Abstract/Full Text Posted July 2023